Effects of second-line antihyperglycemic drugs on the risk of chronic kidney disease: applying a target trial approach to a hospital-based cohort of Thai patients with type 2 diabetes

Effects of second-line antihyperglycemic drugs on the risk of chronic kidney disease: applying a target trial approach to a hospital-based cohort of Thai patients with type 2 diabetes

Abstract Background The reno-protective effect of second-line treatments in type 2 diabetes has been assessed by clinical trials but generalizability to routine clinical practice is still uncertain. We aimed to assess the effectiveness of these treatments, when added to metformin, on the risk of chr...

Full description

Bibliographic Details
Main Authors: Sukanya Siriyotha, Thitiya Lukkunaprasit, Panu Looareesuwan, Hataikarn Nimitphong, Gareth J. McKay, John Attia, Ammarin Thakkinstian
Format: Article
Language:English
Published: BMC 2022-11-01
Series:Cardiovascular Diabetology
Subjects:
Antihyperglycemic drugs
Chronic kidney disease
Sodium-glucose cotransporter-2 inhibitors
Type 2 diabetes
Online Access:https://doi.org/10.1186/s12933-022-01641-2

Similar Items

Similar Items